Aprutumab

Aprutumab Suppliers list
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:Aprutumab (anti-FGFR2)
CAS:1634620-63-5
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:$119.9/100μg;$588.9/1mg;$1851.9/5mg;$2598.9/10mg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 17754423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Aprutumab
CAS:1634620-63-5
Purity:95% Package:100ug;500ug;1mg
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Products Intro: Product Name:Aprutumab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310
Email: marketing@tsbiochem.com
Products Intro: Product Name:Aprutumab
CAS:1634620-63-5
Purity:SDS-PAGE:95% SEC-HPLC:98.69% Package:1mg/RMB 4320;5mg/RMB 8900;10mg/RMB 12200
Company Name: Biolab Reagents  
Tel: 027-65279366 18162686757
Email: products@biolabreagent.com
Products Intro: Product Name:Research Grade Aprutumab(DHD47902)
CAS:1634620-63-5
Purity:PAGE:>95% Package:100ug;1mg
Aprutumab Basic information
Product Name:Aprutumab
Synonyms:Aprutumab;Research Grade Aprutumab(DHD47902);Aprutumab (anti-FGFR2);FGFR-moAb|||FGFR2-TTC|||BAY 1179470
CAS:1634620-63-5
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Aprutumab Structure
Aprutumab Chemical Properties
storage temp. Store at -20°C
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Aprutumab Usage And Synthesis
UsesAprutumabis a fully human FGFR2 monoclonal antibody, which binds to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. Aprutumab has the potential for solid tumors research.
Mechanism of actionType-2 fibroblast growth factor receptor antagonists
Aprutumab Preparation Products And Raw materials
Tag:Aprutumab(1634620-63-5) Related Product Information
Panitumumab Trastuzumab Abciximab Nimotuzumab Matuzumab Pertuzumab Batoclimab Nipocalimab Rozanolixizumab OMALIZUMAB